Medication info

Hyalogic (Prefilled) (Sodium Hyaluronate)

Prescription medicationInjectionsInjection
Ingredient · strength
Sodium Hyaluronate›10mg / 1mL
Manufacturer / importer
NexPharm Korea Co., Ltd.
Appearance
A colorless transparent viscous liquid contained in a prefilled glass syringe (part of the prefilled syringe system) sealed at both ends with rubber caps.
Packaging
2.0mL/vial X 3
Approval status
Active

MFDS item code 201708497 · Notified 2017.12.21 · Insurance code 662503831

Summary

Main use
Treatment of knee osteoarthritis and shoulder periarthritis
Who receives it
Adults
Adult administration
Usually, in adults, administer 1 syringe into the knee joint or shoulder joint (glenohumeral joint, subacromial bursa, or tendon sheath of the long head of the biceps) once weekly for 3 consecutive weeks. The number of doses may be adjusted as appropriate according to symptoms. Since this drug is administered intra-articularly, use strict aseptic technique.

Ingredients

Manufacturer
NexPharm Korea Co., Ltd.

Efficacy & effects

Treatment of knee osteoarthritis and shoulder periarthritis

  • Knee osteoarthritis
  • shoulder periarthritis
View approved original text

This medication is used for the treatment of knee osteoarthritis and shoulder periarthritis.

How it is given

Adult administration

Usually, in adults, administer 1 syringe into the knee joint or shoulder joint (glenohumeral joint, subacromial bursa, or tendon sheath of the long head of the biceps) once weekly for 3 consecutive weeks. The number of doses may be adjusted as appropriate according to symptoms. Since this drug is administered intra-articularly, use strict aseptic technique.

Precautions

This medication should not be used in patients who are hypersensitive to any of its components. Caution should be exercised in patients who have had allergies to other medications or have liver dysfunction or a history of liver disease. Additionally, if there are skin lesions or infections at the injection site, the condition should be carefully checked before administration. Severe allergic reactions including shock may occur, so patients should be closely monitored after administration, and if any unusual symptoms appear, administration should be stopped immediately and appropriate treatment should be provided. Allergic symptoms such as swelling, redness, itching, or rash around the face or eyes may occur, so if these symptoms appear, stop using the medication and consult with a healthcare professional. Temporary pain, swelling, redness, warmth, or pressure may occur at the joint where the injection is given, so patients should be prepared for these symptoms. Symptoms such as nausea, vomiting, and fever may also occur rarely, so inform a healthcare professional if these symptoms arise. Administering this medication to inflamed joints may worsen the inflammation, so it is advisable to use it after the inflammation has subsided. It is important to stabilize the joint area after administration and ensure that the medication does not leak out of the joint. This medication should be administered under strict aseptic conditions, and if symptoms do not improve, administration should be stopped after three doses. If there is fluid accumulation in the joint, it is advisable to drain the fluid as needed before administration. This medication should not be injected intravenously or directly into the eye, and using a needle with a gauge of approximately 22-23 is appropriate. Also, care should be taken as precipitate may form if used with sterilizing disinfectants. Women who are pregnant or may become pregnant should use this medication cautiously, as its safety during pregnancy is not established, and only when the benefits outweigh the risks. During breastfeeding, this medication may be transmitted through breast milk, so it is advisable to avoid breastfeeding during treatment. Safety has not been established in children, so it should be used with caution only if necessary. Elderly patients may have diminished bodily functions, so special precautions should be taken when using this medication.

Side effects

Shock symptoms, edema (facial, eyelid, etc.), facial flushing, rash, hives, itching, pain (mainly transient pain after administration), swelling, anasarca, redness, warmth, severe local pressure, nausea, vomiting, fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and kept in a dark place away from direct light. Additionally, the storage temperature should be maintained between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

A colorless transparent viscous liquid contained in a prefilled glass syringe (part of the prefilled syringe system) sealed at both ends with rubber caps.

Package unit

2.0mL/vial X 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.